Gone are the days when we were looking at Digital Therapeutics (DTx) as ‘the future of healthcare.’ As we all are well aware, the global pandemic that ensued due to COVID 19 compelled the healthcare industry, among others, to explore DTx more seriously as opposed to it being an afterthought or an adjunct under normal circumstances. But now the times have changed. DTx has moved from musings and debates of ‘the future of healthcare’ to a feasible, viable option that is rapidly occupying the centre stage of healthcare.

To read the full article, you need to Purchase this issue. CLICK HERE TO ORDER NOW.